Serum calcium, phosphate and alkaline phosphate levels in epileptic children treated with phenobarbitone.
A longitudinal study to estimate the serum calcium, phosphate and alkaline phosphatase levels of 89 ambulatory epileptic children, aged between 3 years and 12 years, and having generalised tonic-clonic seizures, was carried out. None was on any form of medication for the treatment of seizures prior to presentation. Each patient received only phenobarbitone during the period of study. Serum levels of the biochemical parameters were determined at presentation, 6 months and 12 months, while serum phenobarbitone levels were estimated at 6 months and 12 months. Mean serum calcium, phosphate and alkaline phosphatase of the patients remained within the normal range. Using the paired 't' test, the differences in the levels of the parameters at the three measurements were not statistically significant (P > 0.05). Serum phenobarbitone levels remained within the therapeutic range during the period of study. Our results show that over a 12-month period, serum levels of calcium, phosphate, and alkaline phosphatase, remain normal in ambulant epileptic children treated with phenobarbitone.
Ojinnaka
N C
NC
Department of Paediatrics, University of Nigeria Teaching Hospital, Enugu, Nigeria.
Iloeje
S O
SO
D000469:Alkaline Phosphatase / Q000097:blood*; D000927:Anticonvulsants / Q000627:therapeutic use*; D002118:Calcium / Q000097:blood*; D002648:Child; D002675:Child, Preschool; D016903:Drug Monitoring; D004830:Epilepsy, Tonic-Clonic / Q000097:blood* / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008137:Longitudinal Studies; D008297:Male; D010634:Phenobarbital / Q000627:therapeutic use*; D010710:Phosphates / Q000097:blood*
D000927:Anticonvulsants; D010710:Phosphates; D000469:Alkaline Phosphatase; D002118:Calcium; D010634:Phenobarbital